Macular Degeneration

The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with minimal impact on the corneal endothelium, according to a study published in Heliyon.

Occasionally, treatments come along that are of greater interest to patients than to doctors.

Throughout history, all medical decision-making has relied upon anecdote, expert opinion, and cumbersome and limited clinical trials with delayed or nonexistent post hoc analysis and validation.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses the company’s shift to a retina-focused program.

The past 2 years have brought a decisive leap forward in the management of age-related macular degeneration.

VSP Vision has launched AARP Vision Plans from VSP, which includes a number of vision and eye wear insurance options tailored to the needs of AARP members.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Caroline Baumal, MD, presents data from the GALE study on pegcetacoplan for geographic atrophy in macular degeneration.

Ocutrx Technologies has released its OcuLenz augmented reality/extended reality headset, which is designed to enhance visual clarity for people with advanced macular degeneration.

Another landmark moment in eye care occurred this year with the approval of pegcetacoplan, known as Syfovre from Apellis Pharmaceuticals, allowing treatment for the geographic atrophy form of macular degeneration.